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lternative Site Pacing
o Promote Cardiac Synchrony
as Conventional Pacing
ecome Unconventional?*
ark H. Schoenfeld, MD, FACC
ew Haven, Connecticut
early five decades have transpired since the advent of
ransvenous right ventricular apical (RVA) pacing, during
hich time millions of paced patients have derived signifi-
ant benefit with regard to amelioration of symptoms and
ongevity. Recent studies, however, suggest that this tech-
ique may indeed be nonphysiologic by promoting cardiac
yssynchrony and compromising hemodynamic function
1–4). This has led to a consideration of alternative ap-
roaches to cardiac pacing (5–7).
See pages 1927 and 1938
In 1925, Wiggers (8) first demonstrated acute left ven-
ricular (LV) dysfunction from RVA pacing in animals,
ubsequently shown to result from slower transmyocardial
onduction as opposed to the normally rapid ventricular
ctivation seen during sinus rhythm or atrial pacing in the
etting of intact atrioventricular (AV) nodal/Purkinje con-
uction (9). Myofibrillar disarray (10) and increases in in-
ramyocardial catecholamine concentrations (11) have also
een observed in association with RVA pacing. Early
tudies in humans demonstrated pacing-induced cardiac
yssynchrony as assessed by radionuclide angiography, re-
ulting in a deterioration in cardiac performance (12). These
ndings have been substantiated by more recent evaluations
f young patients subjected to long-term RVA pacing with
onsequent LV dilation, dysfunction, and deleterious re-
odeling (13,14). Depression in LV ejection fraction (15)
nd myocardial perfusion defects (16) may extend over time.
A number of large scale trials have also highlighted the
otentially detrimental effect of RVA pacing on cardiac
unction and patient symptomatology. Thus, Andersen
t al. (17) examined 225 patients with sick sinus syndrome,
redominantly New York Heart Association (NYHA)
unctional class 0 to II, randomized to single-chamber atrial
r ventricular pacing and found a higher incidence of
ongestive heart failure (CHF) in the latter group, evident
nly upon longer-term follow-up (17). In the Dual Cham-
er and VVI Implantable Defibrillator (DAVID) trial,
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.s
From the Cardiac Electrophysiology and Pacer Laboratory, Hospital of Saint
aphael, Yale University School of Medicine, New Haven, Connecticut.mplantable cardioverter defibrillator (ICD) patients with
lready depressed cardiac function were randomized to
DDR pacing at a relatively short AV interval versus
entricular backup pacing at 40/min; increased RVA pacing
bserved in the former group was associated with a signif-
cantly higher incidence of new or worsened CHF (1).
urther analysis demonstrated that the percent right ven-
ricular pacing was predictive of the outcome of death or
HF hospitalization in this trial (4). Similar results were
bserved in the subset of Multicenter Automatic Defibril-
ator Implantation Trial (MADIT)-II ICD patients with an
jection fraction 30% who were predominantly RVA-
aced (3). The Mode Selection Trial (MOST) randomized
,010 sinus node dysfunction patients and a preserved ejection
raction to dual chamber versus RVA pacing and found a
eduction in signs and symptoms of CHF dual-chamber
atients (18). However, when Sweeney et al. (2) subse-
uently examined a subset of 1,339 MOST study patients
ith a normal baseline QRS duration, they found that a
igher cumulative percent RVA paced rhythm was strongly
redictive of CHF hospitalization regardless of whether these
atients were programmed to DDDR or VVIR pacing.
As a result, alternatives to RVA pacing have been
onsidered. Minimizing RVA pacing may be attempted by
rogramming extended AV delay, AV search hysteresis, or
inimum ventricular pacing algorithms that search for and
romote intrinsic AV conduction (6,19). Right ventricular
utflow tract pacing has been utilized, with mixed results
20). Upgrade from RVA pacing to biventricular (BiV)
acing has been associated with improvement in LV func-
ion and alleviation of CHF (21–23).
This issue of the Journal is noteworthy for presenting two
apers (24,25) on prophylactic usage of unconventional
acing sites to minimize cardiac desynchronization in pa-
ients with standard pacing indications. They are both
rossover, blinded, and randomized studies that, despite a
mall patient sampling, demonstrate significant functional
nd symptomatic improvement compared with conventional
VA pacing.
In the first study, Occhetta et al. (24) report on 16
atients with chronic atrial fibrillation (AF) and narrow
RS duration who underwent AV node ablation. All
atients received both RVA pacing leads as well as active
xation leads placed to allow for direct His-bundle pacing
r para-Hisian stimulation. Selective His-bundle pacing
as first described in dog preparations by Scherlag et al.
26). In a feasibility study, Deshmukh et al. (27) demon-
trated that direct His-bundle pacing was a viable approach
or permanent cardiac pacing in patients with dilated cardio-
yopathy. This technique coupled with rate control
achieved pharmacologically or via AV node ablation) was
uccessful in reducing LV dimensions and improving car-
iac function. It remains unclear how much of the improve-
ent reflected His-bundle pacing versus rate control in the
etting of a tachycardia-mediated cardiomyopathy: there
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May 16, 2006:1946–8 Editorial Commentas no RVA pacing limb for comparison. Subsequently,
hese workers did assess a small subgroup of cardiomyopa-
hy patients who also received a lead for RVA pacing; in a
oncrossover, nonblinded evaluation they demonstrated in-
reased cardiopulmonary reserve with direct His-bundle
acing (28). In contrast, the current work by Occhetta et al.
24) examined patients predominantly with preserved car-
iac function at baseline (ejection fraction 50% in the
ajority with a mean ejection fraction of 52% for the
roup), and employed an RVA pacing control mode. They
onvincingly demonstrated a marked improvement in mul-
iple parameters when His-bundle or para-Hisian pacing
as compared with RVA pacing: interventricular electro-
echanical delay, NYHA functional classification, quality-
f-life scores. Although promising, His-bundle lead place-
ent is technically challenging. It is important to
ifferentiate sites that allow true para-Hisian pacing from
hose that indirectly capture the His bundle (28), and potential
pplicability to patients with intraventricular conduction
elay is unknown. It remains unclear whether there is
ncremental benefit in patients with greater preexistent LV
ysfunction.
In the study by Kindermann et al. (25), BiV pacing was
rospectively evaluated as an alternative to RVA pacing in
0 patients with a range of bradycardic conditions; the
ajority also had left bundle branch block. This was a very
ick cohort with mean NYHA functional class 3 and mean
V ejection fraction of 26%. There are potentially con-
ounding variables. Thus, half of the patients had right
entricular leads implanted in the septum and the remainder
n the apex; of the coronary sinus leads, one third were
laced in the anterolateral position. Despite efforts at cardio-
ersion during the lead-in period, some patients remained in
F. Rate-adaptive pacing was not universally employed.
espite these limitations, when compared with RVA pac-
ng, BiV pacing resulted in significant reductions in LV
olumes, N-terminal pro-B-type natriuretic peptide levels,
nd quality-of-life scores, while improving LV ejection
raction and exercise capacity. This differs from results
btained by Brignole et al. (29) who found little or no added
enefit of LV or BiV pacing when compared with RVA
acing in AF patients undergoing AV junction ablation. It
s, however, consonant with findings obtained by the Left
entricular-Based Cardiac Stimulation Post-AV Nodal
blation Evaluation (PAVE) study, in 184 AF patients
ith AV node ablation, in whom BiV pacing resulted in
mprovement in 6-min walk and LV ejection fraction
ompared with RVA pacing when prospectively evaluated
30).
Given the long track record associated with RVA pacing,
t may be premature to abandon conventional pacing in
avor of alternative sites. Certainly, additional prospective
andomized clinical trials are warranted (31). It is of interest
hat the recently published United Kingdom Pacing and
ardiovascular Events (UKPACE) randomized trial of
,021 patients with high-grade AV block reported only a.2% subsequent annual event rate for heart failure in
ingle-chamber pacing and 3.3% rate for dual-chamber
acing—no significant difference in a group of patients in
hom nearly three quarters had baseline NYHA functional
lass II or III (32). There remain too many unexamined
ariables, such as how preexistent structural heart disease
ay impact upon pacing mode selection. There has been
ome impression, for example, that RVA pacing may be
ore deleterious in patients with chronic LV dysfunction
25,33,34). Equally uncertain is how underlying indication
or pacing may affect the choice of pacing modality. In the
acemaker Selection in the Elderly (PASE) trial, for exam-
le, quality-of-life benefits associated with dual-chamber
acing compared with RVA pacing were primarily observed
n patients with sinus-node dysfunction (35). It is unclear,
herefore, whether certain subsets of patients (as opposed to
ll patients) may be identified as deriving particular benefit
rom alternative site pacing.
Beyond this, other issues must be addressed in advance of
he widespread adoption of these techniques in patients who
equire pacemaker therapy. Lead delivery systems need to be
efined, and training for implanters must rise to the occasion
36). Sufficient implant volumes and implanter proficiency
or alternative site pacing must be demonstrated to ensure
cceptable patient outcomes as expanding guidelines evolve.
ost-effectiveness is always a consideration. Ultimately,
e must choose to be “selective” in our choice of pacing
odality (5) by individualizing therapy based on a number
f clinical and nonclinical variables. For some patients, the
nce-preferred right ventricular apex may become an “alter-
ative” site, and what was once conventional may become
nconventional.
eprint requests and correspondence: Dr. Mark H. Schoenfeld,
ardiac Electrophysiology and Pacer Laboratory, Hospital of
aint Raphael, Yale University School of Medicine, 330 Orchard
treet, Suite #210, New Haven, Connecticut 06511. E-mail:
schoenfeld@srhs.org.
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